Scopus Biopharma Inc Stock price
Is Scopus Biopharma Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
Scopus Biopharma Inc Stock Analysis
Analyst Opinions
7 Analysts have issued a Scopus Biopharma Inc forecast:
Analyst Opinions
7 Analysts have issued a Scopus Biopharma Inc forecast:
Don't miss a Thing! We will send you all news about Scopus Biopharma Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Scopus Biopharma, Inc. is a biopharmaceutical company, which engages in the development of transformational therapeutics targeting serious diseases with unmet medical needs. Its drug candidates comprises of combination of cannabidiol-mediated, opioid-sparing anesthetics, synthesis of cannabinoids, and cannabinoid receptor mediating compounds for the treatment of systemic sclerosis. The company was founded on April 18, 2017 and is headquartered in New York, NY.
| Head office | United States |
| CEO | Dr. Horsager |
| Employees | 13 |
| Founded | 2017 |
| Website | scopusbiopharma.com |


